Concurrent expression of KDM5C and PBRM1, which encodes a subunit of the SWI/SNF chromatin remodeling complex, is present in up to 10% of RCC tumors, enriched in patients with favorable risk disease, and associated with longer time on VEGF TKI therapy [38]. Here, PBRM1 is linked to renal cell carcinoma.